Alexis Leonard

1.4k total citations
44 papers, 748 citations indexed

About

Alexis Leonard is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Alexis Leonard has authored 44 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 15 papers in Molecular Biology and 14 papers in Hematology. Recurrent topics in Alexis Leonard's work include Hemoglobinopathies and Related Disorders (26 papers), Prenatal Screening and Diagnostics (11 papers) and Virus-based gene therapy research (8 papers). Alexis Leonard is often cited by papers focused on Hemoglobinopathies and Related Disorders (26 papers), Prenatal Screening and Diagnostics (11 papers) and Virus-based gene therapy research (8 papers). Alexis Leonard collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Alexis Leonard's co-authors include John F. Tisdale, Selami Demirci, Naoya Uchida, Juan J. Haro‐Mora, Henry R. Costantino, Steven C. Quay, Johannes Wolff, Anthony Sileno, Gordon Brandt and Allistair Abraham and has published in prestigious journals such as Blood, The Journal of Immunology and Human Molecular Genetics.

In The Last Decade

Alexis Leonard

41 papers receiving 724 citations

Peers

Countries citing papers authored by Alexis Leonard

Since Specialization

Citations

This map shows the geographic impact of Alexis Leonard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis Leonard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis Leonard more than expected).

Fields of papers citing papers by Alexis Leonard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis Leonard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis Leonard. The network helps show where Alexis Leonard may publish in the future.

Co-authorship network of co-authors of Alexis Leonard

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis Leonard. A scholar is included among the top collaborators of Alexis Leonard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis Leonard. Alexis Leonard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond the traditional oncology patient: the role of palliative care in patients with sickle cell disease receiving stem cell transplantation or gene therapy 2025 ·Frontiers in Oncology ·(unknown), Deena R. Levine, Alexis Leonard, Akshay Sharma, Liza‐Marie Johnson	0
2	Clinical data comparison for FDA-approved gene therapies in sickle cell disease 2025 ·Experimental Biology and Medicine ·Alexis Leonard, Julie Kanter	0
3	Genome editing strategies for targeted correction of β-globin mutation in sickle cell disease: From bench to bedside 2025 ·Molecular Therapy ·(unknown), (unknown), (unknown), Taylor T. Johnson, (unknown), Alexis Leonard, John F. Tisdale, Selami Demirci	0
4	Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease 2024 ·Blood ·Alexis Leonard, Akshay Sharma, Yogindra Persaud, (unknown), Danielle L Pickett, R U Massey, (unknown), (unknown), Salem Akel, (unknown), Yan Zheng, Ella Sorani, (unknown), Mitchell J. Weiss, Stephen Gottschalk, Julie Kanter, Matthew M. Hsieh, John F. Tisdale	2
5	Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models 2024 ·Cytotherapy ·Selami Demirci, (unknown), (unknown), Anh‐Tuan Le, Alexis Leonard, (unknown), (unknown), Xiong Liu, Jing Zeng, (unknown), Rebecca Chu, Naoya Uchida, Daisuke Araki, (unknown), (unknown), Stacy A. Maitland, Daniel E. Bauer, Scot A. Wolfe, André Larochelle, John F. Tisdale	1
6	Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease 2024 ·Annals of the American Thoracic Society ·A. Parker Ruhl, Ruba Shalhoub, Neal Jeffries, (unknown), Alexis Leonard, Amisha V. Barochia, John F. Tisdale, Courtney D. Fitzhugh, Matthew M. Hsieh	1
7	Hematopoietic stem cell collection for sickle cell disease gene therapy 2024 ·Current Opinion in Hematology ·Alexis Leonard, Mitchell J. Weiss	7
8	Gene therapy for sickle cell disease 2023 ·Hematology ·Alexis Leonard, John F. Tisdale	10
9	Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital 2023 ·Frontiers in Medicine ·(unknown), Deepika S. Darbari, (unknown), Robert Sheppard Nickel, Alexis Leonard, (unknown), (unknown), (unknown), Jen Webb, Suvankar Majumdar, Matthew Sharron, Andrew Campbell	4
10	Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease 2022 ·British Journal of Haematology ·Akshay Sharma, Alexis Leonard, Kamille A. West, Jeffrey M. Gossett, Naoya Uchida, Sandhya R. Panch, David F. Stroncek, (unknown), Salem Akel, Jane S. Hankins, Courtney D. Fitzhugh, Matthew M. Hsieh, Guolian Kang, John F. Tisdale, Mitchell J. Weiss, Yan Zheng	13
11	Gene Therapy for Hemoglobinopathies 2022 ·Hematology/Oncology Clinics of North America ·Alexis Leonard, John F. Tisdale, Melissa Bonner	26
12	Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation 2021 ·Cytotherapy ·Alexis Leonard, Alice Bertaina, Carmem Bonfim, Sandra Cohen, Susan E. Prockop, Duncan Purtill, (unknown), Jaap Jan Boelens, Robert Wynn, Annalisa Ruggeri, Allistair Abraham	12
13	CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease 2021 ·Molecular Therapy — Methods & Clinical Development ·Selami Demirci, Alexis Leonard, (unknown), John F. Tisdale	25
14	Efficacy and safety of long-term sirolimus use as part of multidisciplinary care in a pediatric patient with CLOVES syndrome: Case report 2021 ·Alexis Leonard, Yaser Diab, Laura L. Tosi	1
15	Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation 2020 ·Stem Cell Research & Therapy ·Selami Demirci, Juan J. Haro‐Mora, Alexis Leonard, Claire Drysdale, Daniela Malide, Keyvan Keyvanfar, (unknown), Raul Vizcardo, Naritaka Tamaoki, Nicholas P. Restifo, John F. Tisdale, Naoya Uchida	19
16	Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives 2020 ·Stem Cells Translational Medicine ·Selami Demirci, Alexis Leonard, John F. Tisdale	48
17	Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn 2019 ·Transfusion ·Alexis Leonard, (unknown), (unknown), (unknown), Cyril Jacquot, Naomi L.C. Luban, Deepika S. Darbari, Jennifer Webb	20
18	CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges 2019 ·Advances in experimental medicine and biology ·Selami Demirci, Alexis Leonard, Juan J. Haro‐Mora, Naoya Uchida, John F. Tisdale	42
19	In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo 2006 ·International Journal of Pharmaceutics ·Alexis Leonard, Anthony Sileno, Gordon Brandt, C A Foerder, Steven C. Quay, Henry R. Costantino	45
20	Development of a novel high-concentration galantamine formulation suitable for intranasal delivery 2005 ·Journal of Pharmaceutical Sciences ·Alexis Leonard, Anthony Sileno, (unknown), C A Foerder, Steven C. Quay, Henry R. Costantino	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact